指南与共识消化、代谢与肾脏急症重症综合管理与镇静镇痛

普通重症监护病房肝衰竭的管理

Management of liver failure in general intensive care unit.
指南 / 共识 · Anaesth Crit Care Pain Med · 2019-09-13
一句话结论法国SFAR/AFEF专家共识就普通ICU肝衰竭管理给出18条声明,其中6条高证据等级、7条低证据等级、6条专家意见,1个问题未形成推荐。

法国麻醉与重症医学会(SFAR)和法国肝病研究协会(AFEF)召集23名专家,按GRADE方法制定普通ICU肝衰竭管理指南。指南分为急性肝衰竭和肝硬化ICU患者两部分,前者聚焦病因检查、特异性治疗和对症治疗3个问题,后者涉及ICU转入标准、肾损伤、脓毒症、人血白蛋白、消化道出血、止血管理和专家中心咨询7个问题。最终产生18条声明,经两轮讨论和修订后全部达成强烈共识:6条为高证据等级(Grade 1 ±),7条为低证据等级(Grade 2 ±),6条为专家判断,另有1个问题未提供推荐。

要点

  • SFAR/AFEF共发布18条普通ICU肝衰竭管理声明,全部达成强烈共识,其中6条高证据等级、7条低证据等级、6条专家判断。
  • 指南分急性肝衰竭与肝硬化ICU患者两大部分,急性肝衰竭围绕病因检查、特异性治疗和对症治疗3个问题。
  • 肝硬化部分覆盖ICU转入标准、肾损伤、脓毒症、人血白蛋白使用、消化道出血、止血管理和专家中心咨询7个问题。
  • 证据分级采用GRADE系统,并强调在低质量证据下作出强推荐的潜在弊端,部分推荐未分级。
  • 有1个问题最终未形成任何推荐。

适用人群与场景

  • 普通重症监护病房(ICU)中的急性肝衰竭患者
  • 普通ICU中的肝硬化患者

研究设计与关键结果

  • 由法国麻醉与重症医学会(SFAR)和法国肝病研究协会(AFEF)组成的23名专家共识委员会制定,采用GRADE系统评估证据质量并形成推荐。
  • 指南聚焦急性肝衰竭的3个问题和肝硬化ICU患者的7个问题,最终产生18条声明。
  • 经两轮讨论和多项修订后,18条声明全部达成强烈共识:6条高证据等级(Grade 1 ±),7条低证据等级(Grade 2 ±),6条为专家判断。
  • 有1个问题未提供推荐。

证据类型、等级与局限

  • 证据类型:基于GRADE系统的法国SFAR/AFEF专家共识指南。
  • 证据等级:6条高证据等级(Grade 1 ±),7条低证据等级(Grade 2 ±),6条专家判断,部分推荐未分级。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 原文未据此给出推荐

指南或共识出处

  • 法国麻醉与重症医学会(SFAR)与法国肝病研究协会(AFEF)联合制定的《普通重症监护病房肝衰竭的管理》指南

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To produce French guidelines on Management of Liver failure in general Intensive Care Unit (ICU).

DESIGN: A consensus committee of 23 experts from the French Society of Anesthesiology and Critical Care Medicine (Société française d'anesthésie et de réanimation, SFAR) and the French Association for the Study of the Liver (Association française pour l'étude du foie, AFEF) was convened. A formal conflict-of-interest (COI) policy was developed at the start of the process and enforced throughout. The entire guideline process was conducted independently of any industrial funding. The authors were advised to follow the principles of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system to guide their assessment of the quality of evidence. The potential drawbacks of making strong recommendations in the presence of low-quality evidence were emphasised. Some recommendations were ungraded.

METHODS: Two fields were defined: acute liver failure (ALF) and cirrhotic patients in general ICU. The panel focused on three questions with respect to ALF: (1) Which etiological examinations should be performed to reduce morbidity and mortality? (2) Which specific treatments should be initiated rapidly to reduce morbidity and mortality? (3) Which symptomatic treatment should be initiated rapidly to reduce morbidity and mortality? Seven questions concerning cirrhotic patients were addressed: (1) Which criteria should be used to guide ICU admission of cirrhotic patients in order to improve their prognosis? (2) Which specific management of kidney injury should be implemented to reduce morbidity and mortality in cirrhotic ICU patients? (3) Which specific measures to manage sepsis in order to reduce morbidity and mortality in cirrhotic ICU patients? (4) In which circumstances, human serum albumin should be administered to reduce morbidity and mortality in cirrhotic ICU patients? (5) How should digestive haemorrhage be treated in order to reduce morbidity and mortality in cirrhotic ICU patients? (6) How should haemostasis be managed in order to reduce morbidity and mortality in cirrhotic ICU patients? And (7) When should advice be obtained from an expert centre in order to reduce morbidity and mortality in cirrhotic ICU patients? Population, intervention, comparison and outcome (PICO) issues were reviewed and updated as required, and evidence profiles were generated. An analysis of the literature and recommendations was then performed in accordance with the GRADE® methodology.

RESULTS: The SFAR/AFEF Guidelines panel produced 18 statements on liver failure in general ICU. After two rounds of debate and various amendments, a strong agreement was reached on 100% of the recommendations: six had a high level of evidence (Grade 1 ±), seven had a low level of evidence (Grade 2 ±) and six were expert judgments. Finally, no recommendation was provided with respect to one question.

CONCLUSIONS: Substantial agreement exists among experts regarding numerous strong recommendations on the optimum care of patients with liver failure in general ICU.

来源:Anaesth Crit Care Pain Med,查看原文。版权归原作者所有。

参考来源

  1. Paugam-Burtz C, Levesque E, Louvet A, et al. Management of liver failure in general intensive care unit. Anaesth Crit Care Pain Med. 2019. PMID: 31525507. doi:10.1016/j.accpm.2019.06.014

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。